Amendola Communications, an award-winning healthcare technology and life sciences public relations and marketing firm, has been selected by Peerbridge Health, a developer of a hospital-grade, remote diagnostic and monitoring platform that harnesses artificial intelligence (AI) for early detection of heart failure and other conditions, to implement a national PR program.
Peerbridge Health’s Peerbridge Cor™ is an AI-enabled, 3-lead, 2-channel wireless ambulatory ECG device that has shown a nearly 96% accuracy rate in identifying heart failure in patients utilizing ECG as the only input. Amendola will work with Peerbridge Health to educate the industry on the life-saving potential of early detection of heart failure through AI-enabled remote monitoring technology.